NCT04248179View on ClinicalTrials.gov

The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery.

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 29, 2019

Primary Completion Date

December 8, 2021

Study Completion Date

December 8, 2021

Conditions
Breast CancerDuctal Carcinoma in Situ
Interventions
DRUG

Ropivacaine injection

Ropivacaine 5mg/ml

DRUG

Saline 0.9%

Saline 0.9%

DRUG

Sufentanil and PONV prophylaxis

30 minutes prior to emergence 0.2 μg/kg total body weight Sufentanil IV and 1 gram of paracetamol IV (if 6hrs since preoperative medicine) and 4 mg ondansetron IV (PONV prophylaxis) will be administered.

Trial Locations (1)

4000

Department of Anaesthesiology and Intensive Care Medicine, Zealand University Hospital, Roskilde, Roskilde

All Listed Sponsors
collaborator

Copenhagen University Hospital, Denmark

OTHER

lead

Zealand University Hospital

OTHER

NCT04248179 - The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery. | Biotech Hunter | Biotech Hunter